Rima Patel
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer (NCT06637306) | Rima Patel | 2025-03-05 |
Track Rima Patel automatically
Every clearance here is in the API, with alerts when new ones post.